tadalafil has been researched along with solifenacin succinate in 6 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 522 | 194 | 343 |
| Protein | Taxonomy | tadalafil (IC50) | solifenacin succinate (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.5737 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0635 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.1308 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamasco, L; Gualà, L; Maselli, G; Pace, G; Silvestri, V; Vicentini, C | 1 |
| De Nunzio, C; Tubaro, A | 1 |
| Pannek, J | 1 |
| Anjiki, H; Hagiwara, K; Hayashida, M; Kurosawa, K; Nagamoto, S; Ogawa, K; Oka, S; Okaneya, T; Sakaguchi, K; Urakami, S; Yano, A | 1 |
| Eisner, BH; Hinojosa-Gonzalez, DE; Segall, MR | 1 |
| Azis, A; Ciayadi, TA; Hendarto, J; Kholis, K; Palinrungi, MA; Syahrir, S; Syarif, S | 1 |
3 review(s) available for tadalafil and solifenacin succinate
| Article | Year |
|---|---|
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
Topics: Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Drug Combinations; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Solifenacin Succinate; Sulfonamides; Tadalafil; Tamsulosin; Transurethral Resection of Prostate; Urological Agents | 2015 |
[Overactive bladder-which treatment when?]
Topics: Behavior Therapy; Botulinum Toxins, Type A; Diagnosis, Differential; Electric Stimulation Therapy; Female; Gabapentin; Humans; Injections, Intramuscular; Lumbosacral Plexus; Male; Muscarinic Antagonists; Patient Preference; Physical Therapy Modalities; Solifenacin Succinate; Tadalafil; Urinary Bladder; Urinary Bladder, Overactive | 2017 |
Pharmacological Management of Ureteral Stent-related Symptoms: A Systematic Review, Bayesian Network Meta-analysis, and Meta-regression.
Topics: Bayes Theorem; Cholinergic Antagonists; Humans; Network Meta-Analysis; Pain; Prospective Studies; Quality of Life; Solifenacin Succinate; Stents; Tadalafil; Ureter | 2023 |
3 trial(s) available for tadalafil and solifenacin succinate
| Article | Year |
|---|---|
Tadalafil versus solifenacin for persistent storage symptoms after prostate surgery in patients with erectile dysfunction: a prospective randomized study.
Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Muscarinic Antagonists; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Surveys and Questionnaires; Tadalafil; Tetrahydroisoquinolines; Therapeutics; Urination Disorders; Urodynamics | 2011 |
Effect of tadalafil add-on therapy in patients with persistant storage symptoms refractory to α
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Pilot Projects; Prostatic Hyperplasia; Prostatism; Severity of Illness Index; Solifenacin Succinate; Tadalafil; Urological Agents | 2019 |
A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms.
Topics: Humans; Pain; Quality of Life; Solifenacin Succinate; Stents; Tadalafil; Urological Agents | 2023 |